Wholesale of pharmaceutical and medical goods
BIOGEN NORWAY AS
Revenue 2024
NOK 287.9m
Operating profit
NOK 10.1m
Equity
NOK 185.2m
Incorporated
1999
Employees
8
Share capital
NOK 100,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 287.9m | |
| Total operating costs | 277.9m | |
| Operating profit (EBIT) | 10.1m | |
| Net financial items | 5.4m | |
| Profit for the year | 12.1m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 233.9m | |
| of which current assets | 233.7m | |
| Equity | 185.2m | |
| Total liabilities | 48.7m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.